PharmaShots Weekly Snapshots (November 22-26, 2021)
Kintor Pharma Receives NMPA’s IND Clearance for KX-826 to Treat Male Androgenetic Alopecia (AGA)
Published: Nov 26, 2021 | Tags: Kintor Pharma, NMPA, IND, KX-826, Male Androgenetic Alopecia
Published: Nov 26, 2021 | Tags: Selecta Biosciences, US, FDA, Clinical Hold, P-I/II, Clinical Trial, SEL-302, Methylmalonic Acidemia
Published: Nov 26, 2021 | Tags: Aadi Bioscience, Fyarro, US, FDA, Approval, Malignant, Perivascular Epithelioid Cell Tumor
Published: Nov 26, 2021 | Tags: Johnson & Johnson, COVID-19 Vaccine, Health Canada, Approval, COVID-19
Published: Nov 26, 2021 | Tags: Chugai, Herceptin, MHLW, Approval, HER2-Positive, Salivary Gland Cancer
Published: Nov 26, 2021 | Tags: Pfizer, BioNTech, Comirnaty, CHMP, COVID-19
Published: Nov 25, 2021 | Tags: Arctic Vision, P-III, Study, ARVN001, Macular Edema, Uveitis, UME
Published: Nov 25, 2021 | Tags: BeiGene, Brukinsa, zanubrutinib, EC, Approval, Waldenström’s Macroglobulinemia
Janssen Signs an Option Agreement with Philogen to Discover Small Molecule Therapeutics
Published: Nov 25, 2021 | Tags: Janssen, Philogen, Small Molecule Therapeutics
Published: Nov 25, 2021 | Tags: Pfizer, Vupanorsen, P-IIb, TRANSLATE-TIMI 70 Study, Dyslipidemia
Published: Nov 25, 2021 | Tags: Kura Oncology, US, FDA, Clinical Hold, P-Ib, Study, KO-539, Acute Myeloid Leukemia
Gilead and Merck Pause Enrollment in P-II Study of Islatravir + Lenacapavir for the Treatment of HIV
Published: Nov 25, 2021 | Tags: Gilead, Merck, P-II, Study, Islatravir, Lenacapavir, HIV
BMS’ Zeposia (ozanimod) Receives EC‘s Approval for the Treatment of Ulcerative Colitis
Published: Nov 24, 2021 | Tags: BMS, Zeposia, ozanimod, EC, Approval, Ulcerative Colitis
Published: Nov 24, 2021 | Tags: Hutchmed, AstraZeneca, P-III, SACHI Trial, Orpathys, Tagrisso, Non-Small Cell Lung Cancer
Published: Nov 24, 2021 | Tags: Takeda, Livtencity, maribavir, US, FDA, Approval, Cytomegalovirus Infection
Published: Nov 24, 2021 | Tags: Scynexis, Brexafemme, Ibrexafungerp, P-III, VANISH-306 Study, Vaginal Yeast Infection
Published: Nov 24, 2021 | Tags: Apollomics, P-III, Clinical Trial, Uproleselan, AML
Published: Nov 24, 2021 | Tags: Galapagos, P-II, MANGROVE Trial, GLPG2737, Polycystic Kidney Disease
Published: Nov 23, 2021 | Tags: Neurocrine, Sosei Heptares, Muscarinic Receptor Agonists, Schizophrenia, Neuropsychiatric Disorders
Published: Nov 23, 2021 | Tags: Arrowhead, GSK, ARO-HSD, Nonalcoholic Steatohepatitis
Twist Bioscience to Acquire Abveris for ~$190M
Published: Nov 23, 2021 | Tags: Twist Bioscience, Acquire, Abveris, ~$190M
Pfizer and BioNTech Report Results of COVID-19 Vaccine in P-III Trial for the Treatment of COVID-19
Published: Nov 23, 2021 | Tags: Pfizer, BioNTech, COVID-19 Vaccine, P-III, Trial, for COVID-19
Published: Nov 23, 2021 | Tags: Regeneron, Nykode, Vaccines, Cancer, Infectious Diseases
Published: Nov 23, 2021 | Tags: Mirati, Verastem, Adagrasib + VS-6766 for KRASG12C-Mutant NSCLC
Published: Nov 22, 2021 | Tags: BridgeBio, Helsinn, GPX4 Inhibitor, Multiple Cancer
Published: Nov 22, 2021 | Tags: Innovent, Sintilimab, P-III, ORIENT-31 Study, EGFR-Mutated, Non squamous, Non-small Cell Lung Cancer, ESMO 2021
Published: Nov 22, 2021 | Tags: CStone, Jiangsu Hengrui, CS1002, Greater China
Zenas Acquires Exclusive WW Rights of Xencor's obexelimab for the Treatment of Autoimmune Diseases
Published: Nov 22, 2021 | Tags: Zenas, Acquires, Xencor, obexelimab, Autoimmune Diseases
Gilead Submits BLA to US FDA for Bulevirtide to Treat Chronic Hepatitis Delta Virus Infection
Published: Nov 22, 2021 | Tags: Gilead, BLA, US, FDA, Bulevirtide, Chronic Hepatitis Delta Virus Infection
Published: Nov 22, 2021 | Tags: UCB, Bimekizumab, P-III, BE OPTIMAL Study, Active Psoriatic Arthritis
Related post: PharmaShots Weekly Snapshots (November 15-19, 2021)